|
|||||||||||||||||||||||||
![]() |
SaturdayInternational Approvals:Rivastigmine Tartrate (Exelon) for Parkinson's Dementia in EU
more...medscape
: "On March 9, the European Commission (EC) approved a new indication for rivastigmine tartrate capsules and oral solution (Exelon, made by Novartis Pharmaceuticals, Inc), allowing their use for the symptomatic treatment of mild to moderately severe dementia in patients with idiopathic Parkinson's disease (PD). " |